Intelligent Bio Solutions Inc. (INBS)

USD 1.28

(4.51%)

Operating Expenses Summary of Intelligent Bio Solutions Inc.

  • Intelligent Bio Solutions Inc.'s latest annual operating expenses in 2024 was 11.7 Million USD , up 33.61% from previous year.
  • Intelligent Bio Solutions Inc.'s latest quarterly operating expenses in 2024 FY was 9.25 Million USD , up 5.65% from previous quarter.
  • Intelligent Bio Solutions Inc. reported a annual operating expenses of 8.76 Million USD in annual operating expenses 2023, up 5.11% from previous year.
  • Intelligent Bio Solutions Inc. reported a annual operating expenses of 8.33 Million USD in annual operating expenses 2022, up 18.55% from previous year.
  • Intelligent Bio Solutions Inc. reported a quarterly operating expenses of 2.75 Million USD for 2024 Q1, up 2.56% from previous quarter.
  • Intelligent Bio Solutions Inc. reported a quarterly operating expenses of 2.19 Million USD for 2024 Q2, down -20.59% from previous quarter.

Annual Operating Expenses Chart of Intelligent Bio Solutions Inc. (2024 - 2017)

Historical Annual Operating Expenses of Intelligent Bio Solutions Inc. (2024 - 2017)

Year Operating Expenses Operating Expenses Growth
2024 11.7 Million USD 33.61%
2023 8.76 Million USD 5.11%
2022 8.33 Million USD 18.55%
2021 7.03 Million USD 148.68%
2020 2.82 Million USD -57.98%
2019 6.72 Million USD 46.19%
2018 4.6 Million USD 2561.01%
2017 172.99 Thousand USD 0.0%

Peer Operating Expenses Comparison of Intelligent Bio Solutions Inc.

Name Operating Expenses Operating Expenses Difference
OpGen, Inc. 30.65 Million USD 61.808%
Standard BioTools Inc. 113.48 Million USD 89.683%
Aspira Women's Health Inc. 24.11 Million USD 51.444%
bioAffinity Technologies, Inc. 8.76 Million USD -33.588%
Castle Biosciences, Inc. 242.78 Million USD 95.177%
Exact Sciences Corporation 2.06 Billion USD 99.432%
IDEXX Laboratories, Inc. 1.09 Billion USD 98.929%
iSpecimen Inc. 16.27 Million USD 28.067%
Inotiv, Inc. 246.9 Million USD 95.258%
Psychemedics Corporation 11.33 Million USD -3.307%
RadNet, Inc. 268.87 Million USD 95.645%
Prenetics Global Limited 60.73 Million USD 80.722%
Neuronetics, Inc. 82.25 Million USD 85.766%
Star Equity Holdings, Inc. 16.27 Million USD 28.043%
Exagen Inc. 52.29 Million USD 77.609%
Bionano Genomics, Inc. 148.99 Million USD 92.141%
CareDx, Inc 277.76 Million USD 95.785%
Check-Cap Ltd. 19.28 Million USD 39.292%
Twist Bioscience Corporation 354.18 Million USD 96.694%
Guardant Health, Inc. 901.62 Million USD 98.701%
Biodesix, Inc. 77.41 Million USD 84.876%
BioNexus Gene Lab Corp. 3.92 Million USD -198.459%
Precipio, Inc. 13.63 Million USD 14.146%
Natera, Inc. 938.98 Million USD 98.753%
Fulgent Genetics, Inc. 171.9 Million USD 93.189%
Sera Prognostics, Inc. 39.91 Million USD 70.667%
23andMe Holding Co. 420.73 Million USD 97.217%
OPKO Health, Inc. 574.68 Million USD 97.963%
Personalis, Inc. 128.14 Million USD 90.863%
Aclaris Therapeutics, Inc. 110.52 Million USD 89.406%
Applied DNA Sciences, Inc. 16.48 Million USD 28.98%
T2 Biosystems, Inc. 41.49 Million USD 71.782%
Neogen Corporation 405.23 Million USD 97.111%
Myriad Genetics, Inc. 600.1 Million USD 98.049%
ICON Public Limited Company 755.64 Million USD 98.45%
NeoGenomics, Inc. 341.25 Million USD 96.569%
Star Equity Holdings, Inc. 16.27 Million USD 28.043%
MDxHealth SA 71.25 Million USD 83.568%
Prenetics Global Limited 60.73 Million USD 80.722%
Illumina, Inc. 3.81 Billion USD 99.693%
DarioHealth Corp. 62.17 Million USD 81.167%
ENDRA Life Sciences Inc. 10.52 Million USD -11.293%
Medpace Holdings, Inc. 187.68 Million USD 93.761%
Mainz Biomed B.V. 27.15 Million USD 56.881%
Trinity Biotech plc 46.49 Million USD 74.817%
Sotera Health Company 300.46 Million USD 96.103%
bioAffinity Technologies, Inc. 8.76 Million USD -33.588%